P. Mulders

Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer

S. Taneja, N. Fleshner, H. Payne, 2008, Prostate Cancer and Prostatic Diseases.

Safety and ef fi cacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as fi rst-line therapy in patients with advanced non-small-cell lung cancer

M. Gore, V. Matveev, J. Bellmunt, 2013 .

Renal cell cancer: chromosome 3 translocations as risk factors.

A. V. van Kessel, M. Ligtenberg, A. Smits, 1999, Journal of the National Cancer Institute.

A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN.

M. Gore, B. Melichar, V. Matveev, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

BEVLiN: Prospective study of the safety and efficacy of first-line bevacizumab (BEV) plus low-dose interferon-α2a (IFN) in patients (pts) with metastatic renal cell carcinoma (mRCC).

M. Gore, B. Melichar, V. Matveev, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosome 3 translocations and the risk to develop renal cell cancer: a Dutch intergroup study.

N. Hoogerbrugge, C. V. van Ravenswaaij, A. Geurts van Kessel, 2003, Genetic counseling.

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report.

S. Aamdal, J. Wanders, A. Eggermont, 2003, European journal of cancer.

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

J. Rossi, N. James, U. Prabhakar, 2010, British Journal of Cancer.

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.

C. Porta, A. Ravaud, V. Flamand, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.

K. Aben, A. Vrieling, J. Sedelaar, 2021, Clinical nutrition.